Frontlight ResearchEarly access
Trial site
Fuzhou
- 3running trials
- 1closed trial
The trials here
What the 4 trials at this site are about, from their registry records.
- Conditions
- Phase
- Phase 33 trials
- Phase 21 trial
- Status
- Active, not recruiting2 trials
- Completed1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Sanofi3 trials
- Bioverativ, a Sanofi company1 trial
Running trials
Enrolling by invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026